Provided by Tiger Trade Technology Pte. Ltd.

Mind Medicine (MindMed) Inc.

15.02
0.0000
Volume:- -
Turnover:30.63M
Market Cap:1.48B
PE:-7.60
High:15.02
Open:15.02
Low:15.02
Close:15.02
52wk High:15.29
52wk Low:4.70
Shares:98.51M
Float Shares:91.33M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9758
EPS(LYR):-1.5424
ROE:-85.59%
ROA:-33.95%
PB:11.33
PE(LYR):-9.74

Loading ...

Mind Medicine rebrands to Definium Therapeutics

TIPRANKS
·
Jan 12

Mind Medicine (MindMed) Inc: Company Shares Will Trade Under New Nasdaq Ticker Symbol "Dftx"

THOMSON REUTERS
·
Jan 12

MindMed Highlights Phase 3 Progress and Billion-Dollar Potential in Anxiety and Depression Therapies

Reuters
·
Jan 12

Mind Medicine MindMed Initiated at Buy by Jones Trading

Dow Jones
·
Dec 23, 2025

MindMed Grants Stock Options to New Employees as Hiring Incentive

Reuters
·
Dec 16, 2025

MindMed Grants Stock Options to New Employees

Reuters
·
Dec 02, 2025

MindMed Q3 Net Income USD -67.265 Million

Reuters
·
Nov 20, 2025

Stock Track | Mind Medicine (MindMed) Soars 5.28% Following H.C. Wainwright's Buy Rating Reiteration

Stock Track
·
Nov 12, 2025

Stock Track | Mind Medicine (MindMed) Soars 5.28% Following H.C. Wainwright's Buy Rating Reiteration

Stock Track
·
Nov 12, 2025

H.C. Wainwright Sticks to Its Buy Rating for Mind Medicine (MNMD)

TIPRANKS
·
Nov 11, 2025

Stock Track | Mind Medicine (MindMed) Soars 5.38% After Evercore ISI Maintains Buy Rating

Stock Track
·
Nov 10, 2025

Stock Track | Mind Medicine (MindMed) Soars 5.38% as Evercore ISI Maintains Buy Rating

Stock Track
·
Nov 10, 2025

Mind Medicine (MNMD) Receives a Buy from Evercore ISI

TIPRANKS
·
Nov 10, 2025

Mind Medicine MindMed Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Nov 08, 2025

RBC Adjusts Price Target on Mind Medicine to $20 From $21, Maintains Outperform Rating

MT Newswires Live
·
Nov 08, 2025

Mind Medicine price target raised to $25 from $16 at Canaccord

TIPRANKS
·
Nov 07, 2025

Mind Medicine (MindMed) Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 07, 2025

MindMed Showcases Late-Stage Pipeline Progress and Psychiatric Drug Milestones in New Corporate Presentation

Reuters
·
Nov 07, 2025

MindMed Q3 net loss widens to $67.3 mln

Reuters
·
Nov 07, 2025

MindMed reports Q3 2025 results and updates cash position

Reuters
·
Nov 07, 2025